Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Creative Commons License

Ordu Ç., Selcuk N. A., ERDOĞAN E. B., Angın G., Güral Z., Memiş H., ...More

MEDICINE, vol.93, no.28, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 93 Issue: 28
  • Publication Date: 2014
  • Doi Number: 10.1097/md.0000000000000299
  • Journal Name: MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bezmialem Vakıf University Affiliated: Yes


The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).